Cite
HARVARD Citation
Tseng, W. et al. (2021). Defining the role of neoadjuvant systemic therapy in high‐risk retroperitoneal sarcoma: A multi‐institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group. Cancer. 127 (5), pp. 729-738. [Online].